Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision marker at the bottom of the page has been updated from v3.6.6 to v3.7.0, reflecting a recent system/UI update to the study history view. This change does not modify any study data or visible content beyond version labeling.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the Record History page, signaling a newer build of the record view.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now shows an added revision entry v3.6.5 and the previous revision v3.6.4 was removed. This update reflects changes to the page's version history rather than to trial data or content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new build of the page and updating the version shown in the history.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.3, superseding the previous v3.6.2. This indicates an update to the record's content or metadata.SummaryDifference0.1%

- Check101 days agoChange Detected- The page's revision label updated from v3.6.0 to v3.6.2 in the record history. This change indicates a newer version of the page's history UI and does not alter the study data, eligibility, status, or presented content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.